Proton pump inhibitor and histamine ‐2 receptor antagonist use and risk of liver cancer in two population‐based studies

Alimentary Pharmacology&Therapeutics, EarlyView.

Source: Alimentary Pharmacology and Therapeutics - May 9, 2018 Category: Drugs & Pharmacology Authors: K. T. Tran , Ú. C. McMenamin , B. Hicks , P. Murchie , A. P. Thrift , H. G. Coleman , L. Iversen , B. T. Johnston , A. J. Lee , C. R. Cardwell Source Type: research